Indeed, in vitro and in vivo studies performed in acute promyelocytic leukemia (APL) models demonstrated that HIF-1α levels increased upon the treatment with all-trans retinoic acid (ATRA). This evidence concerns the gene HIF1A and acute promyelocytic leukemia.